Contact
MENU

News and views

Exploring news, ideas,
innovations, and impact

Oct. 08, 2026
Featured

The Adaptive Advocacy Impact Framework

From engagement to impact: A decision-focused approach to measuring the value of patient advocacy across the product life cycle
Learn More

Latest news

New

Supporting the blood cancer community, together

Oct. 09, 2026
Envision Pharma Group, Two Labs, and Riparian to take part in Light The Night on November 7...
Learn More
Share

From publications to evidence ecosystems

Oct. 06, 2026
Eight priorities for future-ready publication leaders...
Learn more

Connected evidence: from insight to impact

Sep. 22, 2026
The future of scientific evidence and publications...
Learn more

What actually moves the needle: measuring the value of patient advocacy

Sep. 01, 2026
Learn more

Envision Pharma Group appoints Ryan Tubbs as Senior Vice President, Commercial Growth

Aug. 25, 2026
New role brings commercial growth and client experience together to support a more connected approach for Envision’s life sciences clients...
Learn more

What actually moves the needle: Redefining patient advocacy impact measures

Jul. 23, 2026
Sign up to receive the white paper and access the Adaptive Advocacy Impact Framework...
Learn more

Envision Pharma Group wins at the 2026 Communiqué Awards, with recognition across four categories

Jul. 14, 2026
Novartis MPN and CML Leaders Programme 2025 honored for measurable impact on rare blood cancer care across the UK...
Learn more

The Envision newsletter

The latest news and thought leadership from Envision Pharma Group, delivered straight to your inbox.